FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2108992076> ?p ?o ?g. }

• W2108992076 endingPage "429" @default.
• W2108992076 startingPage "425" @default.
• W2108992076 abstract "To report a case of hypersensitivity manifesting in a rash, fever, and life-threatening hepatitis in a patient initiated on efavirenz therapy.A 30-year-old Latino male newly diagnosed with HIV was started on efavirenz-based highly active antiretroviral therapy (HAART) using tenofovir 300 mg, emtricitabine 200 mg, and efavirenz 600 mg once daily. Eleven days after beginning therapy, he developed a hypersensitivity reaction manifesting in rash and fever preceding severe drug-induced hepatitis. Liver enzyme peak values were aspartate transaminase 3410 U/L and alanine transaminase 2132 U/L. Hepatitis resolved with discontinuation of the HAART. The patient was rechallenged with tenofovir and emtricitabine one year later; no adverse reactions occurred.The Naranjo probability scale demonstrated a probable relationship between this adverse reaction and efavirenz. A MEDLINE search (2004 to September 2007) revealed 2 cases of rash preceding hepatitis with the initiation of efavirenz. Both cases were in women; there were no prior reported cases of efavirenz hypersensitivity in men. Although the mechanism of this reaction is unknown, a few factors may have contributed to this reaction. The half-life and the auto-induction of efavirenz may explain the continued rise in liver enzymes and severe hepatitis that continued to occur once the drug was discontinued. Another cause that may have contributed is the metabolism of the medication. CYP2B6 is responsible for almost 90% of the clearance of efavirenz. Data from a recent pharmacokinetic study showed that efavirenz concentrations were higher in both black and Latino patients when compared with those of white patients. In addition, it is highly probable that this patient's liver function was impaired when transaminase levels peaked, resulting in decreased clearance of efavirenz.Although such a hypersensitivity reaction is rare, efavirenz is the most probable cause of the erythematous maculopapular rash and acute hepatitis in this patient. Monitoring of liver function in patients who present with a rash following initiation of efavirenz-based HAART is recommended. In addition, clinicians should exercise caution in patients presenting with rash, fever, and increased liver enzymes (> 3 times the upper limit of normal or patient baseline). It is strongly recommended that efavirenz therapy be withheld in such cases and reevaluated once liver enzyme levels stabilize." @default.
• W2108992076 created "2016-06-24" @default.
• W2108992076 creator A5011157970 @default.
• W2108992076 creator A5014894777 @default.
• W2108992076 creator A5033947736 @default.
• W2108992076 creator A5073586334 @default.
• W2108992076 date "2008-02-26" @default.
• W2108992076 modified "2023-10-14" @default.
• W2108992076 title "Efavirenz-Induced Hypersensitivity Reaction Manifesting in Rash and Hepatitis in a Latino Male" @default.
• W2108992076 cites W2029734218 @default.
• W2108992076 cites W2030747457 @default.
• W2108992076 cites W2067978628 @default.
• W2108992076 cites W2075051244 @default.
• W2108992076 cites W2099746597 @default.
• W2108992076 cites W2139322178 @default.
• W2108992076 cites W2141776019 @default.
• W2108992076 cites W2144467620 @default.
• W2108992076 cites W2146431647 @default.
• W2108992076 cites W4236831517 @default.
• W2108992076 cites W52199297 @default.
• W2108992076 doi "https://doi.org/10.1345/aph.1k574" @default.
• W2108992076 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18252833" @default.
• W2108992076 hasPublicationYear "2008" @default.
• W2108992076 type Work @default.
• W2108992076 sameAs 2108992076 @default.
• W2108992076 citedByCount "15" @default.
• W2108992076 countsByYear W21089920762012 @default.
• W2108992076 countsByYear W21089920762013 @default.
• W2108992076 countsByYear W21089920762015 @default.
• W2108992076 countsByYear W21089920762017 @default.
• W2108992076 countsByYear W21089920762019 @default.
• W2108992076 crossrefType "journal-article" @default.
• W2108992076 hasAuthorship W2108992076A5011157970 @default.
• W2108992076 hasAuthorship W2108992076A5014894777 @default.
• W2108992076 hasAuthorship W2108992076A5033947736 @default.
• W2108992076 hasAuthorship W2108992076A5073586334 @default.
• W2108992076 hasConcept C126322002 @default.
• W2108992076 hasConcept C142462285 @default.
• W2108992076 hasConcept C197934379 @default.
• W2108992076 hasConcept C203014093 @default.
• W2108992076 hasConcept C2522874641 @default.
• W2108992076 hasConcept C2776029263 @default.
• W2108992076 hasConcept C2777869810 @default.
• W2108992076 hasConcept C2778570526 @default.
• W2108992076 hasConcept C2778606649 @default.
• W2108992076 hasConcept C2779778239 @default.
• W2108992076 hasConcept C2780035454 @default.
• W2108992076 hasConcept C2780542314 @default.
• W2108992076 hasConcept C2780593183 @default.
• W2108992076 hasConcept C2781432083 @default.
• W2108992076 hasConcept C2993143319 @default.
• W2108992076 hasConcept C2993280485 @default.
• W2108992076 hasConcept C71924100 @default.
• W2108992076 hasConcept C90924648 @default.
• W2108992076 hasConcept C98274493 @default.
• W2108992076 hasConceptScore W2108992076C126322002 @default.
• W2108992076 hasConceptScore W2108992076C142462285 @default.
• W2108992076 hasConceptScore W2108992076C197934379 @default.
• W2108992076 hasConceptScore W2108992076C203014093 @default.
• W2108992076 hasConceptScore W2108992076C2522874641 @default.
• W2108992076 hasConceptScore W2108992076C2776029263 @default.
• W2108992076 hasConceptScore W2108992076C2777869810 @default.
• W2108992076 hasConceptScore W2108992076C2778570526 @default.
• W2108992076 hasConceptScore W2108992076C2778606649 @default.
• W2108992076 hasConceptScore W2108992076C2779778239 @default.
• W2108992076 hasConceptScore W2108992076C2780035454 @default.
• W2108992076 hasConceptScore W2108992076C2780542314 @default.
• W2108992076 hasConceptScore W2108992076C2780593183 @default.
• W2108992076 hasConceptScore W2108992076C2781432083 @default.
• W2108992076 hasConceptScore W2108992076C2993143319 @default.
• W2108992076 hasConceptScore W2108992076C2993280485 @default.
• W2108992076 hasConceptScore W2108992076C71924100 @default.
• W2108992076 hasConceptScore W2108992076C90924648 @default.
• W2108992076 hasConceptScore W2108992076C98274493 @default.
• W2108992076 hasIssue "3" @default.
• W2108992076 hasLocation W21089920761 @default.
• W2108992076 hasLocation W21089920762 @default.
• W2108992076 hasOpenAccess W2108992076 @default.
• W2108992076 hasPrimaryLocation W21089920761 @default.
• W2108992076 hasRelatedWork W1966382437 @default.
• W2108992076 hasRelatedWork W2018725660 @default.
• W2108992076 hasRelatedWork W2024011131 @default.
• W2108992076 hasRelatedWork W2077579298 @default.
• W2108992076 hasRelatedWork W2108992076 @default.
• W2108992076 hasRelatedWork W2118047663 @default.
• W2108992076 hasRelatedWork W2161344308 @default.
• W2108992076 hasRelatedWork W2317831661 @default.
• W2108992076 hasRelatedWork W4312048563 @default.
• W2108992076 hasRelatedWork W631747511 @default.
• W2108992076 hasVolume "42" @default.
• W2108992076 isParatext "false" @default.
• W2108992076 isRetracted "false" @default.
• W2108992076 magId "2108992076" @default.
• W2108992076 workType "article" @default.